Report Detail
Global Pediatric Growth Hormone Market Research Report 2022
- RnM4440823 |
- 17 May, 2022 |
- Global |
- 82 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Growth hormones deficiency is a rare condition but it mainly affects the children. The recombinant form of a growth hormone called somatotropin is generally prescribed to treat pediatric patients with growth hormone deficiency. Somatotropin or growth hormone injections are prescribed for pediatric patients with turner syndrome, short stature, Prader-Willi syndrome, Noonan syndrome and other disorders.
Industry Insights
The global Pediatric Growth Hormone market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Growth Hormone Deficiency accounting for % of the Pediatric Growth Hormone global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Pediatric Growth Hormone market size is valued at US$ million in 2021, while the North America and Europe Pediatric Growth Hormone are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pediatric Growth Hormone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Growth Hormone market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Growth Hormone market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Growth Hormone market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Growth Hormone market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Pediatric Growth Hormone market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Pediatric Growth Hormone Breakdown Data by Indication
Growth Hormone Deficiency
Turner Syndrome
Prader-Willi Syndrome
Noonan Syndrome
Others
Pediatric Growth Hormone Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Regional Analysis
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Merck KGaA
Novo Nordisk A/S
Ferring B.V
Genentech, Inc.
Pfizer Inc.
Eli Lilly & Company
Novartis AG
BioPartners GmbH
Frequently Asked Questions
What factors will challenge the Pediatric Growth Hormone market growth?
Which end-use segment will expand at the fastest CAGR in the Pediatric Growth Hormone market?
Which are the emerging players in the Pediatric Growth Hormone market?
How concentrated is the Pediatric Growth Hormone market?
Which factors are positively contributing to the Pediatric Growth Hormone market growth?
Which are the novel product innovations in the Pediatric Growth Hormone market?
Which product segment will emerge as the most lucrative in the Pediatric Growth Hormone market?
Which factors are increasing the competition in the Pediatric Growth Hormone market?
Which are the strategic measures taken by the Pediatric Growth Hormone industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Pediatric Growth Hormone market in the coming years?
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Indication
- 1.2.1 Global Pediatric Growth Hormone Market Size Growth Rate by Indication: 2017 VS 2021 VS 2028
- 1.2.2 Growth Hormone Deficiency
- 1.2.3 Turner Syndrome
- 1.2.4 Prader-Willi Syndrome
- 1.2.5 Noonan Syndrome
- 1.2.6 Others
- 1.3 Market by Application
- 1.3.1 Global Pediatric Growth Hormone Market Share by Application: 2017 VS 2021 VS 2028
- 1.3.2 Hospital Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 Online Pharmacies
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Pediatric Growth Hormone Market Perspective (2017-2028)
- 2.2 Pediatric Growth Hormone Growth Trends by Region
- 2.2.1 Pediatric Growth Hormone Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Pediatric Growth Hormone Historic Market Size by Region (2017-2022)
- 2.2.3 Pediatric Growth Hormone Forecasted Market Size by Region (2023-2028)
- 2.3 Pediatric Growth Hormone Market Dynamics
- 2.3.1 Pediatric Growth Hormone Industry Trends
- 2.3.2 Pediatric Growth Hormone Market Drivers
- 2.3.3 Pediatric Growth Hormone Market Challenges
- 2.3.4 Pediatric Growth Hormone Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Pediatric Growth Hormone Players by Revenue
- 3.1.1 Global Top Pediatric Growth Hormone Players by Revenue (2017-2022)
- 3.1.2 Global Pediatric Growth Hormone Revenue Market Share by Players (2017-2022)
- 3.2 Global Pediatric Growth Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Pediatric Growth Hormone Revenue
- 3.4 Global Pediatric Growth Hormone Market Concentration Ratio
- 3.4.1 Global Pediatric Growth Hormone Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Pediatric Growth Hormone Revenue in 2021
- 3.5 Pediatric Growth Hormone Key Players Head office and Area Served
- 3.6 Key Players Pediatric Growth Hormone Product Solution and Service
- 3.7 Date of Enter into Pediatric Growth Hormone Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Growth Hormone Breakdown Data by Indication
- 4.1 Global Pediatric Growth Hormone Historic Market Size by Indication (2017-2022)
- 4.2 Global Pediatric Growth Hormone Forecasted Market Size by Indication (2023-2028)
5 Pediatric Growth Hormone Breakdown Data by Application
- 5.1 Global Pediatric Growth Hormone Historic Market Size by Application (2017-2022)
- 5.2 Global Pediatric Growth Hormone Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Pediatric Growth Hormone Market Size (2017-2028)
- 6.2 North America Pediatric Growth Hormone Market Size by Country (2017-2022)
- 6.3 North America Pediatric Growth Hormone Market Size by Country (2023-2028)
- 6.4 United States
- 6.5 Canada
7 Europe
- 7.1 Europe Pediatric Growth Hormone Market Size (2017-2028)
- 7.2 Europe Pediatric Growth Hormone Market Size by Country (2017-2022)
- 7.3 Europe Pediatric Growth Hormone Market Size by Country (2023-2028)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Pediatric Growth Hormone Market Size (2017-2028)
- 8.2 Asia-Pacific Pediatric Growth Hormone Market Size by Country (2017-2022)
- 8.3 Asia-Pacific Pediatric Growth Hormone Market Size by Country (2023-2028)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
9 Latin America
- 9.1 Latin America Pediatric Growth Hormone Market Size (2017-2028)
- 9.2 Latin America Pediatric Growth Hormone Market Size by Country (2017-2022)
- 9.3 Latin America Pediatric Growth Hormone Market Size by Country (2023-2028)
- 9.4 Mexico
- 9.5 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Pediatric Growth Hormone Market Size (2017-2028)
- 10.2 Middle East & Africa Pediatric Growth Hormone Market Size by Country (2017-2022)
- 10.3 Middle East & Africa Pediatric Growth Hormone Market Size by Country (2023-2028)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
11 Key Players Profiles
- 11.1 Merck KGaA
- 11.1.1 Merck KGaA Company Detail
- 11.1.2 Merck KGaA Business Overview
- 11.1.3 Merck KGaA Pediatric Growth Hormone Introduction
- 11.1.4 Merck KGaA Revenue in Pediatric Growth Hormone Business (2017-2022)
- 11.1.5 Merck KGaA Recent Development
- 11.2 Novo Nordisk A/S
- 11.2.1 Novo Nordisk A/S Company Detail
- 11.2.2 Novo Nordisk A/S Business Overview
- 11.2.3 Novo Nordisk A/S Pediatric Growth Hormone Introduction
- 11.2.4 Novo Nordisk A/S Revenue in Pediatric Growth Hormone Business (2017-2022)
- 11.2.5 Novo Nordisk A/S Recent Development
- 11.3 Ferring B.V
- 11.3.1 Ferring B.V Company Detail
- 11.3.2 Ferring B.V Business Overview
- 11.3.3 Ferring B.V Pediatric Growth Hormone Introduction
- 11.3.4 Ferring B.V Revenue in Pediatric Growth Hormone Business (2017-2022)
- 11.3.5 Ferring B.V Recent Development
- 11.4 Genentech, Inc.
- 11.4.1 Genentech, Inc. Company Detail
- 11.4.2 Genentech, Inc. Business Overview
- 11.4.3 Genentech, Inc. Pediatric Growth Hormone Introduction
- 11.4.4 Genentech, Inc. Revenue in Pediatric Growth Hormone Business (2017-2022)
- 11.4.5 Genentech, Inc. Recent Development
- 11.5 Pfizer Inc.
- 11.5.1 Pfizer Inc. Company Detail
- 11.5.2 Pfizer Inc. Business Overview
- 11.5.3 Pfizer Inc. Pediatric Growth Hormone Introduction
- 11.5.4 Pfizer Inc. Revenue in Pediatric Growth Hormone Business (2017-2022)
- 11.5.5 Pfizer Inc. Recent Development
- 11.6 Eli Lilly & Company
- 11.6.1 Eli Lilly & Company Company Detail
- 11.6.2 Eli Lilly & Company Business Overview
- 11.6.3 Eli Lilly & Company Pediatric Growth Hormone Introduction
- 11.6.4 Eli Lilly & Company Revenue in Pediatric Growth Hormone Business (2017-2022)
- 11.6.5 Eli Lilly & Company Recent Development
- 11.7 Novartis AG
- 11.7.1 Novartis AG Company Detail
- 11.7.2 Novartis AG Business Overview
- 11.7.3 Novartis AG Pediatric Growth Hormone Introduction
- 11.7.4 Novartis AG Revenue in Pediatric Growth Hormone Business (2017-2022)
- 11.7.5 Novartis AG Recent Development
- 11.8 BioPartners GmbH
- 11.8.1 BioPartners GmbH Company Detail
- 11.8.2 BioPartners GmbH Business Overview
- 11.8.3 BioPartners GmbH Pediatric Growth Hormone Introduction
- 11.8.4 BioPartners GmbH Revenue in Pediatric Growth Hormone Business (2017-2022)
- 11.8.5 BioPartners GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Pediatric Growth Hormone. Industry analysis & Market Report on Pediatric Growth Hormone is a syndicated market report, published as Global Pediatric Growth Hormone Market Research Report 2022. It is complete Research Study and Industry Analysis of Pediatric Growth Hormone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
